197 related articles for article (PubMed ID: 19526284)
1. Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells.
Das JR; Tizabi Y
Neurotox Res; 2009 Oct; 16(3):194-204. PubMed ID: 19526284
[TBL] [Abstract][Full Text] [Related]
2. Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity.
Copeland RL; Das JR; Kanaan YM; Taylor RE; Tizabi Y
Neurotox Res; 2007 Jul; 12(1):61-9. PubMed ID: 17513200
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
Noh MY; Koh SH; Kim Y; Kim HY; Cho GW; Kim SH
J Neurochem; 2009 Mar; 108(5):1116-25. PubMed ID: 19077054
[TBL] [Abstract][Full Text] [Related]
4. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Arias E; Gallego-Sandín S; Villarroya M; García AG; López MG
J Pharmacol Exp Ther; 2005 Dec; 315(3):1346-53. PubMed ID: 16144975
[TBL] [Abstract][Full Text] [Related]
5. Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated.
Ramlochansingh C; Taylor RE; Tizabi Y
Neurotox Res; 2011 Oct; 20(3):263-9. PubMed ID: 21222065
[TBL] [Abstract][Full Text] [Related]
6. Effects of donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome.
Hayslett RL; Tizabi Y
Pharmacol Biochem Behav; 2003 Dec; 76(3-4):409-15. PubMed ID: 14643839
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease.
Copeland RL; Leggett YA; Kanaan YM; Taylor RE; Tizabi Y
Neurotox Res; 2005 Nov; 8(3-4):289-93. PubMed ID: 16371323
[TBL] [Abstract][Full Text] [Related]
8. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors.
Bontempi B; Whelan KT; Risbrough VB; Lloyd GK; Menzaghi F
Neuropsychopharmacology; 2003 Jul; 28(7):1235-46. PubMed ID: 12700710
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists.
Hellström-Lindahl E; Moore H; Nordberg A
J Neurochem; 2000 Feb; 74(2):777-84. PubMed ID: 10646530
[TBL] [Abstract][Full Text] [Related]
10. Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor.
Serres F; Carney SL
Brain Res; 2006 Jul; 1101(1):36-42. PubMed ID: 16790237
[TBL] [Abstract][Full Text] [Related]
11. The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.
Masuoka T; Kamei C
Psychopharmacology (Berl); 2009 Oct; 206(2):259-65. PubMed ID: 19639304
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholinesterase inhibition reveals endogenous nicotinic modulation of glutamate inputs to CA1 stratum radiatum interneurons in hippocampal slices.
Alkondon M; Albuquerque EX; Pereira EF
Neurotoxicology; 2013 May; 36():72-81. PubMed ID: 23511125
[TBL] [Abstract][Full Text] [Related]
13. Tacrine and donepezil attenuate the neurotoxic effect of A beta(25-35) in rat PC12 cells.
Svensson AL; Nordberg A
Neuroreport; 1998 May; 9(7):1519-22. PubMed ID: 9631459
[TBL] [Abstract][Full Text] [Related]
14. Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3.
Getachew B; Hudson T; Heinbockel T; Csoka AB; Tizabi Y
Neurotox Res; 2018 Oct; 34(3):757-762. PubMed ID: 29804239
[TBL] [Abstract][Full Text] [Related]
15. Suppression of methamphetamine-seeking behavior by nicotinic agonists.
Hiranita T; Nawata Y; Sakimura K; Anggadiredja K; Yamamoto T
Proc Natl Acad Sci U S A; 2006 May; 103(22):8523-7. PubMed ID: 16717181
[TBL] [Abstract][Full Text] [Related]
16. TRPC1 protects human SH-SY5Y cells against salsolinol-induced cytotoxicity by inhibiting apoptosis.
Bollimuntha S; Ebadi M; Singh BB
Brain Res; 2006 Jul; 1099(1):141-9. PubMed ID: 16765919
[TBL] [Abstract][Full Text] [Related]
17. Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease.
Getachew B; Csoka AB; Aschner M; Tizabi Y
Neurochem Int; 2019 Mar; 124():19-24. PubMed ID: 30557592
[TBL] [Abstract][Full Text] [Related]
18. Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors.
Woodruff-Pak DS; Vogel RW; Wenk GL
Neuroscience; 2003; 117(2):439-47. PubMed ID: 12614684
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of nicotine against aminochrome-induced toxicity in substantia nigra derived cells: implications for Parkinson's disease.
Muñoz P; Huenchuguala S; Paris I; Cuevas C; Villa M; Caviedes P; Segura-Aguilar J; Tizabi Y
Neurotox Res; 2012 Aug; 22(2):177-80. PubMed ID: 22528249
[TBL] [Abstract][Full Text] [Related]
20. Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.
Yano K; Koda K; Ago Y; Kobayashi H; Kawasaki T; Takuma K; Matsuda T
Br J Pharmacol; 2009 Jan; 156(1):173-80. PubMed ID: 19133998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
